|
|
||||||||
ORIGINAL RESEARCH |
From the Department of Anesthesiology, University of Tsukuba Institute of Clinical Medicine, Tsukuba City, Ibaraki, Japan.
Address reprint requests to: Yoshitaka Fujii, MD, University of Tsukuba Institute of Clinical Medicine, Department of Anesthesiology, 2-1-1 Amakubo, Tsukuba City, Ibaraki 305-8576, Japan; E-mail: yfujii{at}igaku.md.tsukuba.ac.jp.
OBJECTIVE: To evaluate the efficacy and safety of propofol at subhypnotic doses for reducing emetic symptoms in parturients undergoing cesarean delivery under spinal anesthesia.
METHODS: In a randomized, double-masked trial, 80 patients received lidocaine intravenously 0.1 mg/kg (for injection pain relief) followed by either placebo or propofol at three different doses (0.5 mg/kg per hour, 1.0 mg/kg per hour, 2.0 mg/kg per hour) (n = 20 in each group) immediately after clamping of the umbilical cord. Emetic episodes and safety assessments were performed during spinal anesthesia for cesarean delivery. To estimate a sufficient sample size, it was calculated that 20 patients per group would be required with
= .05 and ß = .2.
RESULTS: The rate of patients experiencing no emetic symptoms in an intraoperative, postdelivery period was 45% with propofol 0.5 mg/kg per hour (P = .5), 80% with propofol 1.0 mg/kg per hour (P = .011), and 80% with propofol 2.0 mg/kg per hour (P = .011), compared with placebo (40%). No clinically serious adverse events caused by the study drugs were observed.
CONCLUSION: Propofol 1.0 mg/kg per hour is the minimum effective subhypnotic dose for reducing emetic symptoms during cesarean delivery. Increasing the dose to 2.0 mg/kg per hour provides no further benefit.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |